• Product NameMyricetin
• Brief DescriptionInhibitors
• Purification99.85%
• Biological ActivityMyricetin is produced from the parent compound taxifolin through the (+)-dihydromyricetin intermediate and can be further processed to form laricitrin and then syringetin, both members of the flavonol class of flavonoids. Dihydromyricetin is frequently sold as a supplement and has controversial function as a partial GABAA receptor potentiator and treatment in Alcohol Use Disorder (AUD).
• Target NamePI3K inhibitor
• CAS No. 529-44-2
• Calculated MW 318.24
• Formulation C15H10O8
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Immunology
  SMILES:OC1=CC(O)=C2C(OC(=C(O)C2=O)C2=CC(O)=C(O)C(O)=C2)=C1
  Pathways:PI3K/Akt/mTOR signaling
  Receptor:PI3Kγ
  Boling pt:
  Melting pt:
  Solubility:Ethanol: 20 mg/mL warmed (62.84 mM); DMSO: 63 mg/mL (197.96 mM)
  Appearance:Yellow Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Flamini R, et al. Int J Mol Sci. 2013 Sep 27;14(10):19651-69.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting